1 Introduction to Research & Analysis Reports
1.1 Akabane Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Akabane Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Akabane Vaccines Overall Market Size
2.1 Global Akabane Vaccines Market Size: 2022 VS 2029
2.2 Global Akabane Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Akabane Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Akabane Vaccines Players in Global Market
3.2 Top Global Akabane Vaccines Companies Ranked by Revenue
3.3 Global Akabane Vaccines Revenue by Companies
3.4 Global Akabane Vaccines Sales by Companies
3.5 Global Akabane Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Akabane Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Akabane Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Akabane Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Akabane Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Akabane Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Akabane Vaccines Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type – Global Akabane Vaccines Revenue & Forecasts
4.2.1 By Type – Global Akabane Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Akabane Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Akabane Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Akabane Vaccines Sales & Forecasts
4.3.1 By Type – Global Akabane Vaccines Sales, 2018-2023
4.3.2 By Type – Global Akabane Vaccines Sales, 2024-2029
4.3.3 By Type – Global Akabane Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Akabane Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Akabane Vaccines Market Size, 2022 & 2029
5.1.2 Cattle
5.1.3 Buffalo
5.1.4 Other
5.2 By Application – Global Akabane Vaccines Revenue & Forecasts
5.2.1 By Application – Global Akabane Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Akabane Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Akabane Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Akabane Vaccines Sales & Forecasts
5.3.1 By Application – Global Akabane Vaccines Sales, 2018-2023
5.3.2 By Application – Global Akabane Vaccines Sales, 2024-2029
5.3.3 By Application – Global Akabane Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Akabane Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Akabane Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Akabane Vaccines Revenue & Forecasts
6.2.1 By Region – Global Akabane Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Akabane Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Akabane Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Akabane Vaccines Sales & Forecasts
6.3.1 By Region – Global Akabane Vaccines Sales, 2018-2023
6.3.2 By Region – Global Akabane Vaccines Sales, 2024-2029
6.3.3 By Region – Global Akabane Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Akabane Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Akabane Vaccines Sales, 2018-2029
6.4.3 US Akabane Vaccines Market Size, 2018-2029
6.4.4 Canada Akabane Vaccines Market Size, 2018-2029
6.4.5 Mexico Akabane Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Akabane Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Akabane Vaccines Sales, 2018-2029
6.5.3 Germany Akabane Vaccines Market Size, 2018-2029
6.5.4 France Akabane Vaccines Market Size, 2018-2029
6.5.5 U.K. Akabane Vaccines Market Size, 2018-2029
6.5.6 Italy Akabane Vaccines Market Size, 2018-2029
6.5.7 Russia Akabane Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Akabane Vaccines Market Size, 2018-2029
6.5.9 Benelux Akabane Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Akabane Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Akabane Vaccines Sales, 2018-2029
6.6.3 China Akabane Vaccines Market Size, 2018-2029
6.6.4 Japan Akabane Vaccines Market Size, 2018-2029
6.6.5 South Korea Akabane Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Akabane Vaccines Market Size, 2018-2029
6.6.7 India Akabane Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Akabane Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Akabane Vaccines Sales, 2018-2029
6.7.3 Brazil Akabane Vaccines Market Size, 2018-2029
6.7.4 Argentina Akabane Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Akabane Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Akabane Vaccines Sales, 2018-2029
6.8.3 Turkey Akabane Vaccines Market Size, 2018-2029
6.8.4 Israel Akabane Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Akabane Vaccines Market Size, 2018-2029
6.8.6 UAE Akabane Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAVAC
7.1.1 CAVAC Company Summary
7.1.2 CAVAC Business Overview
7.1.3 CAVAC Akabane Vaccines Major Product Offerings
7.1.4 CAVAC Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 CAVAC Key News & Latest Developments
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Company Summary
7.2.2 Green Cross Veterinary Products Business Overview
7.2.3 Green Cross Veterinary Products Akabane Vaccines Major Product Offerings
7.2.4 Green Cross Veterinary Products Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Green Cross Veterinary Products Key News & Latest Developments
7.3 KAKETSUKEN
7.3.1 KAKETSUKEN Company Summary
7.3.2 KAKETSUKEN Business Overview
7.3.3 KAKETSUKEN Akabane Vaccines Major Product Offerings
7.3.4 KAKETSUKEN Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 KAKETSUKEN Key News & Latest Developments
7.4 Kyoritsu Seiyaku Corporation
7.4.1 Kyoritsu Seiyaku Corporation Company Summary
7.4.2 Kyoritsu Seiyaku Corporation Business Overview
7.4.3 Kyoritsu Seiyaku Corporation Akabane Vaccines Major Product Offerings
7.4.4 Kyoritsu Seiyaku Corporation Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Kyoritsu Seiyaku Corporation Key News & Latest Developments
7.5 Kyoto Biken Laboratories
7.5.1 Kyoto Biken Laboratories Company Summary
7.5.2 Kyoto Biken Laboratories Business Overview
7.5.3 Kyoto Biken Laboratories Akabane Vaccines Major Product Offerings
7.5.4 Kyoto Biken Laboratories Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Kyoto Biken Laboratories Key News & Latest Developments
7.6 Nisseiken
7.6.1 Nisseiken Company Summary
7.6.2 Nisseiken Business Overview
7.6.3 Nisseiken Akabane Vaccines Major Product Offerings
7.6.4 Nisseiken Akabane Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Nisseiken Key News & Latest Developments
8 Global Akabane Vaccines Production Capacity, Analysis
8.1 Global Akabane Vaccines Production Capacity, 2018-2029
8.2 Akabane Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Akabane Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Akabane Vaccines Supply Chain Analysis
10.1 Akabane Vaccines Industry Value Chain
10.2 Akabane Vaccines Upstream Market
10.3 Akabane Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Akabane Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のアカバネワクチン市場予測2023-2029：生ワクチン、死菌ワクチン |
| 【英語タイトル】Akabane Vaccines Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5637 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：71 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のアカバネワクチン市場規模と予測を収録しています。・世界のアカバネワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のアカバネワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のアカバネワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 アカバネワクチンのグローバル主要企業は、CAVAC、 Green Cross Veterinary Products、 KAKETSUKEN、 Kyoritsu Seiyaku Corporation、 Kyoto Biken Laboratories、 Nisseikenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、アカバネワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のアカバネワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のアカバネワクチン市場：タイプ別市場シェア、2022年 ・生ワクチン、死菌ワクチン 世界のアカバネワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のアカバネワクチン市場：用途別市場シェア、2022年 ・牛、水牛、その他 世界のアカバネワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のアカバネワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるアカバネワクチンのグローバル売上、2018年-2023年 ・主要企業におけるアカバネワクチンのグローバル売上シェア、2022年 ・主要企業におけるアカバネワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるアカバネワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CAVAC、 Green Cross Veterinary Products、 KAKETSUKEN、 Kyoritsu Seiyaku Corporation、 Kyoto Biken Laboratories、 Nisseiken ************************************************************* ・調査・分析レポートの概要 アカバネワクチン市場の定義 市場セグメント 世界のアカバネワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のアカバネワクチン市場規模 世界のアカバネワクチン市場規模：2022年 VS 2029年 世界のアカバネワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのアカバネワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のアカバネワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生ワクチン、死菌ワクチン アカバネワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：牛、水牛、その他 アカバネワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別アカバネワクチン市場規模 2022年と2029年 地域別アカバネワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CAVAC、 Green Cross Veterinary Products、 KAKETSUKEN、 Kyoritsu Seiyaku Corporation、 Kyoto Biken Laboratories、 Nisseiken ... |
Vaccine for Akabane disease
This report aims to provide a comprehensive presentation of the global market for Akabane Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Akabane Vaccines. This report contains market size and forecasts of Akabane Vaccines in global, including the following market information:
Global Akabane Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Akabane Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Akabane Vaccines companies in 2022 (%)
The global Akabane Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Akabane Vaccines include CAVAC, Green Cross Veterinary Products, KAKETSUKEN, Kyoritsu Seiyaku Corporation, Kyoto Biken Laboratories and Nisseiken, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Akabane Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Akabane Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Akabane Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Killed Vaccines
Global Akabane Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Akabane Vaccines Market Segment Percentages, by Application, 2022 (%)
Cattle
Buffalo
Other
Global Akabane Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Akabane Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Akabane Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Akabane Vaccines revenues share in global market, 2022 (%)
Key companies Akabane Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Akabane Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CAVAC
Green Cross Veterinary Products
KAKETSUKEN
Kyoritsu Seiyaku Corporation
Kyoto Biken Laboratories
Nisseiken
Outline of Major Chapters:
Chapter 1: Introduces the definition of Akabane Vaccines, market overview.
Chapter 2: Global Akabane Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Akabane Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Akabane Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Akabane Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のアカバネワクチン市場予測2023-2029：生ワクチン、死菌ワクチン] (コード：MMG23JU5637)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のアカバネワクチン市場予測2023-2029：生ワクチン、死菌ワクチン]についてメールでお問い合わせ |
